-
Something wrong with this record ?
Silybin and its congeners: from traditional medicine to molecular effects
V. Křen, K. Valentová
Language English Country Great Britain
Document type Journal Article, Review
PubMed
35510639
DOI
10.1039/d2np00013j
Knihovny.cz E-resources
- MeSH
- Antioxidants pharmacology MeSH
- Silybum marianum chemistry MeSH
- Silybin MeSH
- Silymarin * chemistry pharmacology MeSH
- Medicine, Traditional MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
Covering: 2015 up to 2022 (Feb)Silymarin, an extract of milk thistle (Silybum marianum) fruits, has been used in various medicinal applications since ancient times. A major component of silymarin is the flavonolignan silybin and its relatives isosilybin, silychristin, silydianin, 2,3-dehydrosilybin, and some others. Except for silydianin, they occur in nature as two stereomers. This review focuses on recent developments in chemistry, biosynthesis, modern advanced analytical methods, and transformations of flavonolignans specifically reflecting their chirality. Recently described chemotypes of S. marianum, but also the newest findings regarding the pharmacokinetics, hepatoprotective, antiviral, neuroprotective, and cardioprotective activity, modulation of endocrine functions, modulation of multidrug resistance, and safety of flavonolignans are discussed. A growing number of studies show that the respective diastereomers of flavonolignans have significantly different activities in anisotropic biological systems. Moreover, it is now clear that flavonolignans do not act as antioxidants in vivo, but as specific ligands of biological targets and therefore their chirality is crucial. Many controversies often arise, mainly due to the non-standard composition of this phytopreparation, the use of various undefined mixtures, the misattribution of silymarin vs. silybin, and also the failure to consider the chemistry of the respective components of silymarin.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017963
- 003
- CZ-PrNML
- 005
- 20220804134503.0
- 007
- ta
- 008
- 220720s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1039/d2np00013j $2 doi
- 035 __
- $a (PubMed)35510639
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Křen, Vladimír $u Laboratory of Biotransformation, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, CZ 14220, Czech Republic. kren@biomed.cas.cz $1 https://orcid.org/0000000210914020 $7 xx0070803
- 245 10
- $a Silybin and its congeners: from traditional medicine to molecular effects / $c V. Křen, K. Valentová
- 520 9_
- $a Covering: 2015 up to 2022 (Feb)Silymarin, an extract of milk thistle (Silybum marianum) fruits, has been used in various medicinal applications since ancient times. A major component of silymarin is the flavonolignan silybin and its relatives isosilybin, silychristin, silydianin, 2,3-dehydrosilybin, and some others. Except for silydianin, they occur in nature as two stereomers. This review focuses on recent developments in chemistry, biosynthesis, modern advanced analytical methods, and transformations of flavonolignans specifically reflecting their chirality. Recently described chemotypes of S. marianum, but also the newest findings regarding the pharmacokinetics, hepatoprotective, antiviral, neuroprotective, and cardioprotective activity, modulation of endocrine functions, modulation of multidrug resistance, and safety of flavonolignans are discussed. A growing number of studies show that the respective diastereomers of flavonolignans have significantly different activities in anisotropic biological systems. Moreover, it is now clear that flavonolignans do not act as antioxidants in vivo, but as specific ligands of biological targets and therefore their chirality is crucial. Many controversies often arise, mainly due to the non-standard composition of this phytopreparation, the use of various undefined mixtures, the misattribution of silymarin vs. silybin, and also the failure to consider the chemistry of the respective components of silymarin.
- 650 _2
- $a antioxidancia $x farmakologie $7 D000975
- 650 _2
- $a tradiční lékařství $7 D008519
- 650 _2
- $a ostropestřec mariánský $x chemie $7 D020944
- 650 _2
- $a silibinin $7 D000077385
- 650 12
- $a silymarin $x chemie $x farmakologie $7 D012838
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Valentová, Kateřina $u Laboratory of Biotransformation, Institute of Microbiology of the Czech Academy of Sciences, Vídeňská 1083, Prague 4, CZ 14220, Czech Republic. kren@biomed.cas.cz $1 https://orcid.org/0000000277145350 $7 xx0034397
- 773 0_
- $w MED00005450 $t Natural product reports $x 1460-4752 $g Roč. 39, č. 6 (2022), s. 1264-1281
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35510639 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134456 $b ABA008
- 999 __
- $a ok $b bmc $g 1821854 $s 1169206
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 39 $c 6 $d 1264-1281 $e 20220622 $i 1460-4752 $m Natural product reports $n Nat Prod Rep $x MED00005450
- LZP __
- $a Pubmed-20220720